Clinical Trial Update: Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 1/2 results for the combination of ixabepilone and liposomal doxorubicin in advanced ovarian and related gynecologic ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Fallopian Tube Cancer
• Ovarian Cancer

Drugs mentioned

• Doxil (liposomal doxorubicin)
• Ixabepilone (ixabepilone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Fallopian Tube Cancer, Female Reproductive Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-03-10